GeoVax Labs, Inc. (GOVX) earnings date, results and what the price requires
Nasdaq · SEC CIK 0000832489 · SEC filings checked Oct 16, 2026
Next report
Nov 6, 2026
Estimated from reporting history (103-day cycle, SEC 8-K item 2.02 results filings). Not confirmed.
Last close
$0.26
Polygon.io daily close, Oct 15, 2026. End of day, not live.
Trailing diluted EPS
—
Needs four consecutive reported quarters.
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 27, 2026 | $0 | $-4.4M | — | Filing |
| Mar 31, 2026 | Apr 15, 2026 | $0 | $-5.3M | — | Filing |
| Dec 31, 2025 | Apr 15, 2026 | $0 | $-4.4M | — | Filing |
| Sep 30, 2025 | Nov 13, 2025 | $0 | $-6.3M | — | Filing |
| Jun 30, 2025 | Jul 29, 2025 | $852,282 | $-5.4M | — | Filing |
| Mar 31, 2025 | May 1, 2025 | $1.6M | $-5.4M | — | Filing |
| Dec 31, 2024 | Mar 28, 2025 | $864,415 | $-8.3M | — | Filing |
| Sep 30, 2024 | Nov 13, 2024 | $2.8M | $-5.8M | — | Filing |
What would GeoVax Labs, Inc. have to report for its valuation to change?
Four consecutive reported quarters of diluted EPS are not available in SEC filings. The model is not shown rather than filled with assumptions.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.